Atomoxetine in adolescents with attention deficit hyperactivity disorder (ADHD) and substance use disorder (SUD).

Trial Profile

Atomoxetine in adolescents with attention deficit hyperactivity disorder (ADHD) and substance use disorder (SUD).

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Nov 2012

At a glance

  • Drugs Atomoxetine (Primary)
  • Indications Attention-deficit hyperactivity disorder; Substance-related disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Jul 2008 Updated from NCT (via DMS 30-07-08).
    • 27 Jul 2008 The expected completion date for this trial is now 1 Sep 2012.
    • 05 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top